Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidivarin (CBDV) in Children With Autism Spectrum Disorder
NCT03202303Phase 2Recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Apr 2019
- Primary completion
- Feb 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidivarin in Autism Spectrum Disorder (ASD), sponsored by Montefiore Medical Center. Started Apr 2019; status: recruiting.
02
Drugs
cannabidivarin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03202303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03202303.